Latest Ratios: P/E Ratio 9.0x · EV/EBITDA 16.9x · ROE 15.0%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.6B | $1.7B | $1.3B | $903M | $588M | $644M | $628M | $846M | $684M | $1.1B | $1.2B |
| Enterprise Value | $3.8B | $3.9B | $3.9B | $3.5B | $4.1B | $3.1B | $1.8B | $2.8B | $2.5B | $2.6B | $3.3B |
| P/E Ratio → | 9.04 | 7.30 | 6.35 | 5.44 | 6.38 | 10.25 | 9.89 | 9.85 | 61.79 | 12.93 | 13.26 |
| P/S Ratio | — | — | 4.59 | 3.80 | 4.02 | 6.34 | 6.30 | 6.76 | 9.94 | 8.21 | 8.69 |
| P/B Ratio | 1.22 | 0.99 | 0.98 | 0.75 | 0.55 | 0.65 | 0.60 | 0.83 | 0.69 | 1.01 | 1.14 |
| P/FCF | 4.28 | 4.47 | — | 0.85 | — | — | 0.50 | — | — | 1.49 | 1.49 |
| P/OCF | 4.25 | 4.43 | — | 0.85 | — | — | 0.50 | — | — | 1.48 | 1.47 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | 13.79 | 14.89 | 27.92 | 30.90 | 17.66 | 22.41 | 36.27 | 20.16 | 25.08 |
| EV / EBITDA | 16.94 | 17.24 | 18.75 | 20.88 | 43.06 | 47.45 | 25.90 | 31.32 | 183.63 | 30.77 | 37.38 |
| EV / EBIT | 16.94 | 17.24 | 19.08 | 21.27 | 44.33 | 50.09 | 27.67 | 32.61 | 224.16 | 31.68 | 38.27 |
| EV / FCF | — | 10.55 | — | 3.33 | — | — | 1.41 | — | — | 3.66 | 4.29 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -201.4% | -201.4% | 100.0% | 88.4% | 86.6% | 100.0% | 100.0% | 100.0% | 100.0% | 92.3% | 73.6% |
| Operating Margin | -143.9% | -143.9% | 72.3% | 70.0% | 63.0% | 61.7% | 63.8% | 68.7% | 16.2% | 63.6% | 65.5% |
| Net Profit Margin | -143.9% | -143.9% | 72.3% | 70.0% | 63.0% | 61.7% | 63.8% | 68.7% | 16.2% | 63.6% | 65.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 15.0% | 15.0% | 16.2% | 14.6% | 8.9% | 6.2% | 6.2% | 8.6% | 1.1% | 8.0% | 8.8% |
| ROA | 1.8% | 1.8% | 1.8% | 1.7% | 1.1% | 0.9% | 0.9% | 1.2% | 0.2% | 1.2% | 1.1% |
| ROIC | 2.9% | 2.9% | 2.6% | 2.1% | 1.3% | 1.2% | 1.3% | 1.5% | 0.2% | 1.6% | 1.4% |
| ROCE | 2.7% | 2.7% | 4.8% | 4.3% | 2.8% | 2.2% | 1.5% | 2.1% | 0.5% | 3.2% | 3.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.49 | 2.49 | 3.43 | 3.89 | 4.43 | 3.78 | 1.92 | 3.09 | 3.58 | 2.12 | 3.21 |
| Debt / EBITDA | 18.42 | 18.42 | 21.89 | 27.64 | 49.96 | 56.65 | 29.38 | 35.02 | 261.71 | 26.20 | 36.43 |
| Net Debt / Equity | — | 1.34 | 1.96 | 2.19 | 3.27 | 2.52 | 1.09 | 1.93 | 1.82 | 1.48 | 2.15 |
| Net Debt / EBITDA | 9.94 | 9.94 | 12.51 | 15.55 | 36.85 | 37.72 | 16.66 | 21.87 | 133.32 | 18.24 | 24.43 |
| Debt / FCF | — | 6.08 | — | 2.48 | — | — | 0.91 | — | — | 2.17 | 2.80 |
| Interest Coverage | 0.46 | 0.46 | 0.39 | 0.37 | 0.50 | 1.16 | 0.72 | 0.52 | 0.07 | 0.77 | 0.96 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.75 | 14.75 | 0.30 | 0.33 | 0.23 | 0.25 | 0.25 | 0.76 | 0.36 | 0.18 | 0.26 |
| Quick Ratio | 14.75 | 14.75 | 0.30 | 0.33 | 0.23 | 0.25 | 0.25 | 0.76 | 0.36 | 0.18 | 0.26 |
| Cash Ratio | 14.74 | 14.74 | 0.27 | 0.31 | 0.21 | 0.25 | 0.24 | 0.73 | 0.34 | 0.17 | 0.25 |
| Asset Turnover | — | -0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 4.5% | 5.5% | 5.6% | 4.0% | 6.1% | 6.0% | 7.1% | 7.0% | 9.0% | 5.7% | 5.2% |
| Payout Ratio | 40.5% | 40.5% | 35.4% | 21.8% | 39.3% | 61.5% | 70.2% | 68.4% | 552.5% | 73.9% | 69.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 11.1% | 13.7% | 15.7% | 18.4% | 15.7% | 9.8% | 10.1% | 10.1% | 1.6% | 7.7% | 7.5% |
| FCF Yield | 23.4% | 22.4% | — | 117.4% | — | — | 198.3% | — | — | 67.1% | 67.3% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 9.3% | 0.0% | 0.0% | 0.4% | 0.0% | 0.0% |
| Total Shareholder Yield | 4.5% | 5.5% | 5.6% | 4.0% | 6.1% | 15.3% | 7.1% | 7.0% | 9.4% | 5.7% | 5.2% |
| Shares Outstanding | — | $37M | $37M | $36M | $36M | $39M | $40M | $40M | $40M | $39M | $39M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BLX stock.
Bladex, Inc.'s current P/E ratio is 9.0x. The historical average is 10.9x. This places it at the 46th percentile of its historical range.
Bladex, Inc.'s current EV/EBITDA is 16.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 35.5x.
Bladex, Inc.'s return on equity (ROE) is 15.0%. The historical average is 9.0%.
Based on historical data, Bladex, Inc. is trading at a P/E of 9.0x. This is at the 46th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Bladex, Inc.'s current dividend yield is 4.48% with a payout ratio of 40.5%.
Bladex, Inc. has -201.4% gross margin and -143.9% operating margin.
Bladex, Inc.'s Debt/EBITDA ratio is 18.4x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
Revenue volatility and negative fee income
Discount Valuation Masks Franchise Value
Trading at 1.18x book and 8.7x trailing earnings, BLX's multiples sit below regional peers like CIB at 1.75x book, implying the market prices in a sovereign risk discount despite its preferred creditor status.
The P/B of 1.18x is at a premium to Argentine peers (BBAR 1.22x, BMA 1.33x) but a discount to higher-ROE franchises like CIB (1.75x) and BSAC (2.61x). Given a trailing ROE of only 3.8%, the market appears to assign limited growth premium, consistent with a commodity balance sheet rather than a franchise. The forward P/E of 7.99x suggests expectations of modest earnings recovery, but the negative fee income and provision reversals in 2026Q2 raise questions about earnings quality.
ROE Depressed by Low Leverage and Fee Drag
ROE of 3.8% in 2026Q2, per reported figures, is held back by a 12% equity-to-assets ratio and negative fee income of -$160.5M, which offset a doubling NIM to 1.0%.
DuPont decomposition shows that while NIM improved to 1.0% in 2026Q2, the negative non-interest income contribution (-71.4% of revenue) and a conservative leverage ratio (12.5% equity/assets) cap ROE. The bank's high equity buffer, while prudent, dilutes returns; if management deployed excess capital into higher-yielding assets or returned it via buybacks, ROE could improve. However, the sharp revenue decline (-58% YoY) suggests the loan book is contracting, limiting near-term earnings power.
NIM Doubles but Efficiency Ratio Spikes
NIM expanded to 1.0% in 2026Q2 from 0.5% a year earlier, according to financial statements, yet the efficiency ratio deteriorated to 10.6% as non-interest expenses stayed flat while total revenue fell.
The NIM improvement likely reflects higher yields on floating-rate assets in a rising rate environment, but the efficiency ratio spike indicates that the revenue base is shrinking faster than costs. The negative fee income of -$160.5M in 2026Q2 is a major drag, suggesting trading losses or hedging ineffectiveness. Investors should monitor whether the NIM expansion is sustainable given the contracting loan book and the transition from LIBOR to SOFR, which could cause repricing mismatches.
Equity Buffer Strengthens, ROE Sacrificed
Equity/assets improved to 12.5% in 2026Q2 from 11.3% a year earlier, per balance sheet data, reflecting retained earnings and a shrinking loan book, but this conservative leverage depresses ROE.
The bank's capital position appears robust, with equity growing 38.5% YoY to $1.8B, partly due to reduced risk-weighted assets. While this provides a strong buffer against regional volatility, it also means the bank is under-leveraged relative to peers (D/E of 2.49 vs. BBAR's 0.55). The high dividend yield of 4.6% suggests management is returning capital, but the absence of buybacks and the low leverage indicate a lack of high-return deployment opportunities. If the loan book continues to contract, capital ratios could rise further, pressuring ROE.
Provision Reversals Signal Portfolio Shrinkage
Loan loss provisions turned negative at -$107.1M in 2026Q2, per reported figures, suggesting either improving credit quality or a deliberate reduction in the loan book, which aligns with the -58% revenue decline.
The negative provision expense boosted net income, but it may indicate that the bank is shrinking its loan portfolio rather than experiencing a genuine improvement in credit quality. Given the bank's focus on short-term trade finance, a contraction in trade volumes could be driving this. The high net margin of 66.8% implies the remaining book is profitable, but investors should watch for signs of credit deterioration in key markets like Brazil and Mexico, which could reverse these reversals.
P/E Misleads Due to Provision Volatility
The P/E of 8.74x is distorted by provision reversals and negative fee income in 2026Q2, which artificially boosted earnings; a more reliable metric is P/B at 1.18x, which reflects the bank's tangible book value.
For banks, P/E is often misapplied because provisions can swing earnings dramatically, as seen in 2026Q2 when negative provisions of $107.1M inflated net income. The trailing P/E of 8.74x may understate the bank's true earnings power if provisions normalize. Instead, investors should focus on P/B and ROTCE, which are less volatile. The P/B of 1.18x suggests the market is pricing in a modest premium to book, but given the low ROE, this premium may be justified by the bank's unique preferred creditor status and stable dividend.